Meeting
2023 ASCO Annual Meeting
Phase 1/2, first-in-child study of sonodynamic therapy (SDT) using low intensity focused ultrasound and 5-aminolevulinic acid (ALA) for patients with diffuse intrinsic pontine glioma.
Authors
Hasan R Syed
Children's National Hospital, Washington, DC
Hasan R Syed , Nirali Patel , Lindsay Baker Kilburn , Adriana Fonseca , Kristen Stabingas , Ryan Clanton , Stuart Marcus , Gilbert Vezina , Javad Nazarian , Robert F Keating , Roger J. Packer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Clinical Trial Registration Number
NCT05123534
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS10070)
DOI
10.1200/JCO.2023.41.16_suppl.TPS10070
Abstract #
TPS10070
Poster Bd #
374a
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.
First Author: Sharon L. Gardner
Poster
2019 ASCO Annual Meeting
A TITE-CRM phase I/II study of disulfiram and copper with concurrent radiation therapy and temozolomide for newly diagnosed glioblastoma.
First Author: Jiayi Huang
Poster
2017 ASCO Annual Meeting
Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma multiforme.
First Author: Danielle A. Shafer
Poster
2024 ASCO Annual Meeting
H3B-6545 + palbociclib in patients (pts) with locally advanced/metastatic estrogen receptor-positive (ER+), HER2 negative (–) breast cancer (BC).
First Author: Stephen R. D. Johnston